Professional Titles and Roles
- PhD Supervisor
- Chief Physician
- Director of the Research Department, The First Affiliated Hospital of USTC
- Deputy Director of Hepatobiliary Surgery
Education and Work Experience
- 1996-2001: Bachelor’s in Clinical Medicine, Harbin Medical University
- 2006-2009: Master’s in Surgery, Harbin Medical University
- 2009-2012: PhD in Surgery, Harbin Medical University
- 2001-2006: Physician, Beidaihe Hospital, Qinhuangdao, Hebei
- 2012-2015: Attending Physician, The First Affiliated Hospital of Harbin Medical University
- 2015-2018: Associate Chief Physician, The First Affiliated Hospital of Harbin Medical University
- 2018-2020: Associate Chief Physician, The First Affiliated Hospital of USTC
- 2020-Present: Chief Physician, The First Affiliated Hospital of USTC
Academic Achievements and Impact
- 20 years of medical practice, focusing on comprehensive treatment of hepatobiliary tumors and minimally invasive surgery.
- Supervised 4 master’s students, published over 60 papers in Chinese and English, including 15 SCI-indexed papers, 6 as first author, and 5 teaching papers.
- Co-authored 2 English books.
- Led 8 research projects funded by various organizations, including the Ministry of Science and Technology and the Ministry of Education.
- Awards: First Prize in Scientific and Technological Progress by the Ministry of Education, Second Prize in Heilongjiang Provincial Scientific and Technological Progress, and First Prize in Excellent Teaching Research by the Heilongjiang Higher Education Society.
Academic Positions
Member of multiple committees including:
- Biliary Tumor Professional Committee, Chinese Branch of the International Hepato-Pancreato-Biliary Association
- Biliary Surgery Committee, National Health Commission
- Biliary Surgery Group, Chinese Medical Doctor Association
- Primary Liver Cancer Intelligent Diagnosis and Treatment Committee, Chinese Medical Doctor Association
- Youth Committee, Chinese Anti-Cancer Association
- Digital and Intelligent Surgery Committee, Chinese Research Hospital Association
- Enhanced Recovery After Surgery Committee, Chinese Research Hospital Association
- Gallstone Expert Committee, Chinese Association of Integrative Medicine
- Standing Committee Member, Anhui Medical Association Surgery Branch
- Member, Anhui Provincial Clinical Oncology Society Hepatobiliary-Pancreatic Tumor Surgery Committee
Editorial Boards:
- Chinese Journal of Digestive Surgery
- International Journal of Surgery
- Journal of Hepatobiliary Surgery
- Lingnan Modern Clinical Surgery
Ongoing Projects (Principal Investigator Only)
- Project Name: Development of Clinical Diagnosis and Allergen Detection Products for Food Allergy and Related Standards
- Source: ational Key R&D Program, Food Safety Key Technology Development
- Funding: 0,000 RMB
- Duration: 2019-12 to 2022-12
- Project Name: Application of Near-Infrared II Fluorescent Probes in Laparoscopic Liver Cancer Surgery
- Source:Anhui Provincial Key Research and Development Program
- Funding:300,000 RMB
- Duration: 2021-01 to 2023-12
- Poject Name: Mechanism of SUMOylation of HIF-1α in Regulating the Reverse Warburg Effect in Cholangiocarcinoma
- Source: Heilongjiang Provincial Natural Science Foundation
- Funding: 60,000 RMB
- Duration: 2018-07 to 2021-06
Main Research Directions (Recruitment Specialties) and Content
Surgery
1. Mechanisms and comprehensive treatment of hepatobiliary tumors
2. Minimally invasive treatment in hepatobiliary surgery
Representative Papers (Last Five Years)
1. Dalong Yin#, Changyong Ji#, Shugeng Zhang#, Jiabei Wang, Zhaoyang Lu, Xuan Song, Hongchi Jiang, Wan Yee Lau*, Lianxin Liu*. Clinical characteristics and management of 1,572 patients with pyogenic liver abscess: A 12-year retrospective study. Liver Int, 2021 Apr;41(4):810-818.
2. Huoling Luo#, Dalong Yin#, Shugeng Zhang, Deqiang Xiao, Baochun He, Fanzheng Meng, Yanfang Zhang, Wei Cai, Shenghao He, Wenyu Zhang, Qingmao Hu, Hongrui Guo, Shuhang Liang, Shuo Zhou c, Shuxun Liu, Linmao Sun, Xiao Guo, Chihua Fang, Lianxin Liu*, Fucang Jia*. Augmented reality navigation for liver resection with stereoscopic laparoscope. Comput Methods Programs Biomed. 2020 Apr;187:105099. (Co-first authors)
3. Dalong Yin#, Yingjian Liang#, Tongsen Zheng#, Ruipeng Song#, Jiabei Wang, Boshi Sun, Shangha Pan, Liandong Qu, Jiaren Liu, Hongchi Jiang, Lianxin Liu*. EF24 inhibits tumor growth and metastasis via suppressing NF-kappaB dependent pathways in human cholangiocarcinoma, Sci Rep, 2016 Aug 30;6:32167.
4. Tongsen Zheng#, Dalong Yin#, Zhaoyang Lu#, Jiabei Wang#, Yuejin Li, Xi Chen, Yingjian Liang, Xuan Song, Shuyi Qi, Boshi Sun, Changming Xie, Xianzhi Meng, Shangha Pan, Jiaren Liu, Hongchi Jiang, and Lianxin Liu*. Nutlin-3 overcomes arsenic trioxide resistance and tumor metastasis mediated by mutant p53 in Hepatocellular Carcinoma, Mol Cancer, 2014 May 31;13:133. (Co-first authors)
5. Jiabei Wang#, Dalong Yin#, Changming Xie#, Tongsen Zheng#, Yingjian Liang, Xuehui Hong, Zhaoyang Lu, Xuan Song, Ruipeng Song, Haiyan Yang, Boshi Sun, Nishant Bhatta, Xianzhi Meng, Shangha Pan, Hongchi Jiang, Lianxin Liu*. The iron chelator Dp44mT inhibits hepatocellular carcinoma metastasis via N-Myc downstream-regulated gene 2 (NDRG2)/gp130/STAT3 pathway, Oncotarget, 2014, 5(18):8478-8491. (Co-first authors)
Laboratory Website
Anhui Provincial Key Laboratory of Hepatopancreatobiliary Surgery
Contact Information
E-mail: doctoryin@ustc.edu.cn
Phone: 0551-62284738